BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31206803)

  • 1. Growth phase-dependent changes in the size and infectivity of SDS-resistant Sup35p assemblies associated with the [PSI
    Wang K; Melki R; Kabani M
    Mol Microbiol; 2019 Sep; 112(3):932-943. PubMed ID: 31206803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The three faces of Sup35.
    Lyke DR; Dorweiler JE; Manogaran AL
    Yeast; 2019 Aug; 36(8):465-472. PubMed ID: 30963611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sup35p in Its Soluble and Prion States Is Packaged inside Extracellular Vesicles.
    Kabani M; Melki R
    mBio; 2015 Aug; 6(4):. PubMed ID: 26286691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for the proteasome in the turnover of Sup35p and in [PSI(+) ] prion propagation.
    Kabani M; Redeker V; Melki R
    Mol Microbiol; 2014 May; 92(3):507-28. PubMed ID: 24589377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation within the C-terminal domain of Sup35p that affects [PSI+] prion propagation.
    Kabani M; Cosnier B; Bousset L; Rousset JP; Melki R; Fabret C
    Mol Microbiol; 2011 Aug; 81(3):640-58. PubMed ID: 21631606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles-Encapsulated Yeast Prions and What They Can Tell Us about the Physical Nature of Propagons.
    Kabani M
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of charged residues in the N-domain of Sup35 protein on prion [PSI+] stability and propagation.
    Bondarev SA; Shchepachev VV; Kajava AV; Zhouravleva GA
    J Biol Chem; 2013 Oct; 288(40):28503-13. PubMed ID: 23965990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo [PSI
    Sharma J; Wisniewski BT; Paulson E; Obaoye JO; Merrill SJ; Manogaran AL
    Sci Rep; 2017 Mar; 7(1):76. PubMed ID: 28250435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rnq1 protein protects [PSI^(+)] prion from effect of the PNM mutation].
    Bondarev SA; Likholetova DV; Belousov MV; Zhouravleva GA
    Mol Biol (Mosk); 2017; 51(2):367-371. PubMed ID: 28537243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequestration of essential proteins causes prion associated toxicity in yeast.
    Vishveshwara N; Bradley ME; Liebman SW
    Mol Microbiol; 2009 Sep; 73(6):1101-14. PubMed ID: 19682262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative and quantitative multiplexed proteomic analysis of complex yeast protein fractions that modulate the assembly of the yeast prion Sup35p.
    Redeker V; Hughes C; Savistchenko J; Vissers JP; Melki R
    PLoS One; 2011; 6(9):e23659. PubMed ID: 21931608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for Hsp70 chaperone in Saccharomyces cerevisiae prion seed replication.
    Song Y; Wu YX; Jung G; Tutar Y; Eisenberg E; Greene LE; Masison DC
    Eukaryot Cell; 2005 Feb; 4(2):289-97. PubMed ID: 15701791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Yarrowia lipolytica orthologs of Sup35p assemble into thioflavin T-negative amyloid fibrils.
    Kabani M; Melki R
    Biochem Biophys Res Commun; 2020 Aug; 529(3):533-539. PubMed ID: 32736670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of prions and translation.
    Wickner RB; Edskes HK; Shewmaker FP; Kryndushkin D; Nemecek J; McGlinchey R; Bateman D
    Wiley Interdiscip Rev RNA; 2010; 1(1):81-9. PubMed ID: 21339834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibition of Psi+ prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein.
    Kochneva-Pervukhova NV; Paushkin SV; Kushnirov VV; Cox BS; Tuite MF; Ter-Avanesyan MD
    EMBO J; 1998 Oct; 17(19):5805-10. PubMed ID: 9755180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prolonged chronological lifespan is an unexpected benefit of the [PSI+] prion in yeast.
    Wang K; Melki R; Kabani M
    PLoS One; 2017; 12(9):e0184905. PubMed ID: 28910422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor.
    Paushkin SV; Kushnirov VV; Smirnov VN; Ter-Avanesyan MD
    EMBO J; 1996 Jun; 15(12):3127-34. PubMed ID: 8670813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial sequestration and oligomer remodeling during de novo [PSI
    Lyke DR; Manogaran AL
    Prion; 2017 Sep; 11(5):332-337. PubMed ID: 28968144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curing of yeast [PSI+] prion by guanidine inactivation of Hsp104 does not require cell division.
    Wu YX; Greene LE; Masison DC; Eisenberg E
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12789-94. PubMed ID: 16123122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose availability dictates the export of the soluble and prion forms of Sup35p via periplasmic or extracellular vesicles.
    Kabani M; Pilard M; Melki R
    Mol Microbiol; 2020 Aug; 114(2):322-332. PubMed ID: 32339313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.